Sunday 11 October 2026 Export all EQ data to Excel Powerpack

Equillium, Inc.

EQ Healthcare Biotechnology

Equillium, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $41.1 million, up 13.9% from fiscal 2023. In the quarter to June 2026, revenue fell 52.3%, EPS grew 75.0% and free cash flow fell 38.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.

1.41 0.03 −2.08%
Market cap
$91.3M
P/E
0.0×
Fwd P/E
−5.2×
Dividend yield
—
F-score
3/9
Altman Z
−6.75
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Piotroski F-Score
— 3 — — — — — — —
P/E ratio
— 0.00 0.00 0.00 — — — — —
Altman Z-Score
— (6.75) (4.33) (4.34) — — — — —
P/S ratio
— 0.65 0.70 0.00 — — — — —
P/FCF ratio
— 0.00 0.00 0.00 — — — — —
Altman Z″-Score (non-manufacturers)
— (19.02) (10.24) (8.03) — — — — —
Beneish M-Score
— — (0.88) — — — — — —
P/Operating CF
— (8.04) (4.48) 1.29 — — — — —
P/B ratio
— 1.39 1.12 1.12 — — — — —
Price to Tangible BV
— 1.39 1.12 1.12 — — — — —
EV/Sales
— 0.28 (0.22) 0.00 — — — — —
EV/EBITDA
— 0.00 0.53 0.34 — — — — —
EV/Operating CF
— (0.60) 0.37 3.01 — — — — —
EV/FCF
— (0.60) 0.36 2.92 — — — — —
Quick Ratio
10.32 3.55 1.62 2.31 9.05 11.34 13.69 32.50 12.49
Current Ratio
10.58 3.93 1.79 2.40 9.35 11.76 14.28 33.09 12.57
Net Debt/EBITDA
1.29 2.54 2.70 1.01 1.90 2.48 1.61 7.66 (0.56)
Debt/Assets
0.00% 0.00% 0.00% 11.42% 11.92% 11.64% 17.43% 0.00% 112.69%
Debt/Equity
0.00 0.00 0.00 0.28 0.15 0.14 0.23 0.00 (3.58)
Asset Turnover
0.00 1.08 0.56 0.19 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income
1.02 2.36 1.63 0.14 0.82 0.83 0.90 0.57 0.29
Capex/Depreciation
(0.35) 0.14 0.08 (0.62) (0.09) (0.49) 0.25 (5.83) (22.00)
Interest Coverage
— — (29.58) (58.95) (35.22) (26.89) (95.80) (3.37) (4.51)
ROE
(93.99%) (38.75%) (48.92%) (126.83%) (57.28%) (53.38%) (47.95%) (42.28%) (7.22%)
ROA
(77.92%) (21.19%) (20.68%) (76.21%) (45.72%) (42.30%) (41.73%) (35.66%) (6.09%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(79.23%) (42.72%) (60.36%) (138.46%) (52.28%) (38.14%) (49.57%) (20.34%) (34.36%)
Average Days of Receivables
— 0.00 37.78 65.73 — — — — —
Research and Development Expense of Revenue
0.00% 91.08% 102.65% 384.52% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 29.04% 37.60% 109.39% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 9.13% 11.08% 30.72% 0.00% 0.00% 0.00% 0.00% —
Graham Net Nets
— 0.70 0.84 0.85 — — — — —
Graham Number
— 0.00 0.00 0.00 — — — — —
Earnings Yield
— (30.69%) (53.42%) (179.25%) — — — — —
Free Cash Flow Yield
— (72.07%) (86.13%) (25.21%) — — — — —
Revenue per Share
0.00 1.16 1.04 0.47 0.00 0.00 0.00 0.00 0.00
Operating CF per Share
(0.40) (0.54) (0.63) (0.26) (1.11) (1.21) (1.32) (0.62) (0.07)
Capex per Share
0.00 0.00 0.00 (0.01) 0.00 (0.01) 0.00 0.00 0.00
Free Cash Flow per Share
(0.40) (0.54) (0.63) (0.27) (1.12) (1.22) (1.32) (0.62) (0.07)
Cash per Share
0.53 0.64 1.18 2.11 2.80 4.04 3.06 5.41 0.70
Shareholders Equity per Share
0.50 0.54 0.65 0.95 2.31 3.43 2.41 5.33 (0.22)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.50 0.54 0.65 0.95 2.31 3.43 2.41 5.33 (0.22)
Free Cash Flow
(22.78) (19.11) (21.83) (9.01) (32.14) (24.83) (23.02) (7.56) (0.66)
Working Capital
28.10 18.62 21.78 44.70 74.46 77.93 51.55 65.07 6.58
Capital Expenditures
(0.04) (0.08) (0.05) (0.28) (0.06) (0.20) (0.07) (0.03) 0.00
Net Current Asset Value
27.75 18.44 21.39 30.26 64.47 69.60 41.74 64.87 (2.25)
EV/EBIT
— 0.00 0.55 0.42 — — — — —
Capex to Sales
0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
— 0.00 0.00 0.00 — — — — —
Other line items
Depreciation/Fixed assets
0.62 (2.35) (1.93) 1.15 2.63 1.71 (3.16) 0.09 0.05
Cash ROIC
(38.70%) (45.90%) (34.42%) (8.05%) (20.42%) (15.33%) (22.00%) (5.78%) (5.15%)
Accounts Receivable Turnover
— 0.00 10.98 0.00 — — — — —
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
— — — 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
— — — 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
— — 3.29 — — — — — —
Average Payables
1.72 3.69 4.34 2.60 2.00 2.32 1.50 0.68 0.68
Average Assets
28.75 38.07 64.48 81.91 85.42 70.48 61.35 37.16 37.16
Average Common Equity
23.83 20.82 27.26 49.22 68.18 55.85 53.39 31.34 31.34

Fold the line items

Columns are period end dates